Literature DB >> 27865684

Clinical and molecular characteristics of patients with Gaucher disease in Southern China.

Yuyu Feng1, Yonglan Huang2, Chengfang Tang1, Hao Hu1, Xiaoyuan Zhao1, Huiying Sheng1, Wen Zhang1, Minyi Tan1, Ting Xie1, Jipeng Zheng1, Zongcai Liu1, Xueying Su1, Yongxian Shao1, Xiuzhen Li1, Jing Cheng1, Xiaojian Mao1, Li Liu3.   

Abstract

Gaucher disease (GD) is a common lysosomal storage disorder caused by the deficiency of acid β-glucosidase, due to mutations in the GBA gene. To explore the clinical and molecular characteristics of GD patients from Southern China, GBA gene were analyzed by nest PCR and direct Sanger-sequencing. Novel missense mutations were transiently transfected in COS-7 cells by plasmid system for functional verification. Among the 22 GD patients, 19 patients were classified as type 1 and three as type 2. Over 60% of the type 1 patient had the onset before two years of age and about 42% of them died before three years of age. Six type 1 patients with L444P homozygous genotype, presented with early onset and severe hepatosplenomegaly. Four novel mutations Y22C, F109L, L149F and c.983_990delCCCACTGG were identified. The GBA activities in vitro of novel mutants Y22C, F109L and L149F were 20.2%, 6.9% and 6.5% of the wild-type, respectively. L444P mutation accounted for 47.7% of the mutant alleles. Our results revealed that type 1 GD tends to present with a severe phenotype among southern Chinese. L444P was the most prevalent mutation and L444P homozygous genotype was associated with severe type 1 GD. Three novel missense mutations identified were pathogenic.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Expression study; GBA gene; Gaucher disease; Molecular analysis

Mesh:

Substances:

Year:  2016        PMID: 27865684     DOI: 10.1016/j.bcmd.2016.10.026

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  5 in total

1.  Genetic and clinical characteristics of Filipino patients with Gaucher disease.

Authors:  Mary Anne D Chiong; Marie Julianne C Racoma; Mary Ann R Abacan
Journal:  Mol Genet Metab Rep       Date:  2018-04-05

2.  Three mutations of adult type 1 Gaucher disease found in a Chinese patient: A case report.

Authors:  Xiaoli Du; Qian Ding; Qi Chen; Pengxiang Guo; Qing Wang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

3.  Long-term safety and effectiveness of velaglucerase alfa in Gaucher disease: 6-year interim analysis of a post-marketing surveillance in Japan.

Authors:  Rieko Sagara; Masahide Ishigaki; Manami Otsuka; Kei Murayama; Hiroyuki Ida; Jovelle Fernandez
Journal:  Orphanet J Rare Dis       Date:  2021-12-04       Impact factor: 4.123

4.  Gaucher disease: clinical phenotypes and refining GBA mutational spectrum in Thai patients.

Authors:  Tim Phetthong; Thipwimol Tim-Aroon; Arthaporn Khongkraparn; Saisuda Noojarern; Chulaluck Kuptanon; Khunton Wichajarn; Achara Sathienkijkanchai; Kanya Suphapeetiporn; Pimlak Charoenkwan; Adisak Tantiworawit; Naruwan Noentong; Duangrurdee Wattanasirichaigoon
Journal:  Orphanet J Rare Dis       Date:  2021-12-20       Impact factor: 4.123

5.  Analysis of glucocerebrosidase (GBA) gene mutations in Iranian patients with Gaucher disease.

Authors:  Hadi Mozafari; Mohammad Tghikhani; Zohreh Rahimi; Asad Vaisi Raygani; Shahla Ansari; Shohreh Khatami; Mohammad Reza Alaei; Reza Saghiri
Journal:  Iran J Child Neurol       Date:  2021
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.